Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
6
×
life sciences
national blog main
san francisco blog main
6
×
national top stories
san francisco top stories
boston blog main
boston top stories
new york blog main
gene therapy
new york top stories
san diego blog main
biotech
boston
bristol-myers squibb
clinical data
drugs
fda
roche
san diego top stories
san francisco
acadia pharmaceuticals
adverum biotechnologies
aimmune
alk
allergan
amgen
astellas pharma
atlas venture
audentes therapeutics
avalon ventures
aveo oncology
avidity biosciences
biofourmis
biogen
biomarin
biovotion
bluebird bio
cannabidiol
cerevel therapeutics
What
data
6
×
drug
ago
approved
market
medical
medicine
rare
therapeutics
advanced
analytics
arrival
award
battle
bio
biofourmis
biotechs
cancer
cannabis
close
considering
death
decades
dems
derivative
devices
digital
disease
diseases
dyne
early
employs
epilepsy
expected
experimental
eyes
fatty
fda
form
forward
Language
unset
Current search:
data
×
" san francisco blog main "
×
" clinical trials "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug